M
20
-4
EFX
32
2
PCG
93
2
MA
55
-7
MTCH
37
7
URBN
38
-4
PX
75
5
ACN
47
-2
TDC
75
4
HP
38
-2
PEP
41
6
BAC
50
-3
MRK
22
3
UNH
61
6
APA
21
2
HRB
51
2
DVN
16
3
IR
63
3
HAS
30
2
GRMN
62
-3
M
20
-4
EFX
32
2
PCG
93
2
MA
55
-7
MTCH
37
7
URBN
38
-4
PX
75
5
ACN
47
-2
TDC
75
4
HP
38
-2
PEP
41
6
BAC
50
-3
MRK
22
3
UNH
61
6
APA
21
2
HRB
51
2
DVN
16
3
IR
63
3
HAS
30
2
GRMN
62
-3
Financhill
Back

Genmab AS Vs. Galecto Industry Stock Comparison

Sell
17

GNMSF
Genmab AS

Last Price:
202.36
Seasonality Move:
-0.77%
Sell
17

GLTO
Galecto

Last Price:
5.86
Seasonality Move:
-0.96%
Sell
17
Genmab AS (GNMSF) is a Sell

Is Genmab AS a Buy, Sell or Hold?

  • The current Genmab AS [GNMSF] share price is $202.48. The Score for GNMSF is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
  • GNMSF is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
17
Galecto (GLTO) is a Sell

Is Galecto a Buy, Sell or Hold?

  • The current Galecto [GLTO] share price is $5.81. The Score for GLTO is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
  • GLTO is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

GNMSF Stock Price Chart

What is Genmab AS's stock price today?

  • The Genmab AS share price today is $202.48
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GNMSF is experiencing selling pressure, which indicates risk of future bearish movement.

GLTO Stock Price Chart

What is Galecto's stock price today?

  • The Galecto share price today is $5.81
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GLTO is experiencing selling pressure, which indicates risk of future bearish movement.

GNMSF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -7.08 Sell
Relative Strength Index (14 RSI): 35.52 Sell
Chaikin Money Flow: -365 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (213.7 - 229.94) Sell
Bollinger Bands (100): (228.63 - 270.99) Sell

GLTO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.53 Sell
Relative Strength Index (14 RSI): 25.82 Sell
Chaikin Money Flow: -1903 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (6.44 - 7.26) Sell
Bollinger Bands (100): (0.83 - 10.43) Buy

GNMSF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 215.66 Sell
20-day SMA: 221.05 Sell
50-day SMA: 233.37 Sell
200-day SMA: 267.15 Sell
8-day EMA: 212.26 Sell
20-day EMA: 219.79 Sell
50-day EMA: 232.09 Sell
200-day EMA: 266.24 Sell

GLTO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 6.5 Sell
20-day SMA: 6.84 Sell
50-day SMA: 8.95 Sell
200-day SMA: 3.15 Buy
8-day EMA: 6.34 Sell
20-day EMA: 6.85 Sell
50-day EMA: 7.18 Sell
200-day EMA: 4.34 Buy

Genmab AS Earnings Growth & GNMSF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Galecto Earnings Growth & GLTO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $20.91 per share, and a decrease next year of $0.44 per share.

Genmab AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Galecto Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):